Optiva Securities
  • About us
    • Our Approach
    • Our Team
  • Services
  • Media
  • News
  • Contact
Select Page

Altona Rare Earths PLC: Completion of 2022 Drilling Programme

by Ian Lipman | Dec 7, 2022 | News

Client News Altona Rare Earths PLC: Completion of 2022 Drilling Programme Home / Client News / Altona Rare Earths PLC: Completion of 2022 Drilling Programme Altona (AQSE: ANR.PL), a mining exploration company focused on the evaluation, acquisition and development of...

Sovereign Metals Limited: Sovereign to Demerge Standalone Graphite Projects

by Ian Lipman | Dec 7, 2022 | News

Client News Sovereign Metals Limited: Sovereign to Demerge Standalone Graphite Projects Home / Client News / Sovereign Metals Limited: Sovereign to Demerge Standalone Graphite Projects SOVEREIGN TO DEMERGE STANDALONE GRAPHITE PROJECTS   ·     Sovereign to demerge...

OKYO Pharma Limited: OKYO publicly files a registration statement with the SEC

by Ian Lipman | Dec 6, 2022 | News

Client News OKYO Pharma Limited: OKYO publicly files a registration statement with the SEC Home / Client News / OKYO Pharma Limited: OKYO publicly files a registration statement with the SEC London and New York, N.Y., 6 December 2022 – OKYO Pharma Limited (LSE:...

United Oil & Gas PLC: Commencement of drilling ASW-1X exploration well

by Ian Lipman | Dec 6, 2022 | News

Client News United Oil & Gas PLC: Commencement of drilling ASW-1X exploration well Home / Client News / United Oil & Gas PLC: Commencement of drilling ASW-1X exploration well United Oil & Gas Plc (AIM: “UOG”),  the growing oil and gas company...

Roquefort Therapeutics Plc: Presentation of Midkine Oligonucleotide Program at the European Society of Medical Oncology Asia conference

by Ian Lipman | Dec 5, 2022 | News

Client News Roquefort Therapeutics Plc: Presentation of Midkine Oligonucleotide Program at the European Society of Medical Oncology Asia conference Home / Client News / Roquefort Therapeutics Plc: Presentation of Midkine Oligonucleotide Program at the European Society...
« Older Entries
Next Entries »

Recent Posts

  • Updated agreement to acquire up to 45% interest in Advanced Quicklime Project
  • Roquefort Therapeutics- Midkine Antibody Licencing Deal
  • Upland Resources- Resources Update
  • Upland Resources- Restoration of Trading
  • Upland Resources- Annual Financial Report

Recent Comments

    Archives

    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • September 2023
    • August 2023
    • July 2023
    • June 2023
    • May 2023
    • April 2023
    • March 2023
    • February 2023
    • January 2023
    • December 2022
    • November 2022
    • October 2022
    • September 2022
    • August 2022
    • July 2022
    • June 2022
    • May 2022
    • April 2022
    • March 2022
    • February 2022
    • January 2022
    • December 2021
    • November 2021
    • October 2021
    • September 2021
    • August 2021
    • July 2021
    • June 2021
    • May 2021
    • April 2021
    • March 2021
    • February 2021
    • January 2021
    • December 2020
    • November 2020
    • October 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • June 2019
    • April 2019

    Categories

    • News
    • Uncategorised

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Optiva Securities Ltd
    7 Harp Lane
    London EC3R 7DP

    +44 (0)20 3137 1902
    +44 (0)20 3981 4181
    info@optivasecurities.com
     Optiva Securities

    •  Order Execution Policy
    •  Analysis Policy
    •  Conflicts of Interest Policy
    •  Privacy Notice
    •  Cookies
    •  Complaints Procedure
    •  Disclaimer

    KEEP UPDATED

    Register to stay updated with the latest news.

      We would like to send you occasional emails about our services and keep you up to date with the latest announcements and news. To join our mailing list, simply click below. You can unsubscribe at any time.

      Optiva Securities Limited is authorised and regulated by the United Kingdom Financial Conduct Authority and are Members of the London Stock Exchange.

       

      © Copyright 2026 Optiva Securities Limited. Registered in England number 3068464